Salmonella enterica serovar Enteritidis producing a TEM-52 β-lactamase: first report in Spain

Vázquez, María Dolores Cid; Muñoz‐Bellido, Juan Luis; García, María Inmaculada García; Garcı́a-Rodrı́guez, J.A.

doi:10.1016/j.diagmicrobio.2006.01.020

Cited by 5 publications

(4 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Later on, TEM-5 and TEM-4 were discovered that were found 3 and 4 amino acid different from the parent TEM-1 [ 74 ]. TEM-12 was the 1st TEM-type ESBL detected in Klebsiella oxytoca , isolated in Liverpool, England, in 1982 [ 75 ]. The list is also growing for TEM as new and novel variants are being reported from almost all over the world with the number raising to 223 (14 January 2018) and can be accessed at http://www.lahey.org/Studies/temtable.asp .…”

Section: Types Of Esblsmentioning

confidence: 99%

“…Alongside this, new strains of ESBL carrying with novel types of enzymes of SHV and TEM types are emerging in the Europe indicated by recent reports. Recently, from Spain, isolates of Salmonella were reported carrying TEM-52 [ 75 ], while reports indicated that CTX-m-9 are common in Spain [ 82 ]. Soon after this, a similar resistance feature carrying TEM-52 enzymes E. coli was reported from the United Kingdom broiler chicken farms indicating the quick and successful spread of the emerging resistance features around the globe [ 76 ].…”

Section: Global Epidemiology Of Esblsmentioning

confidence: 99%

See 1 more Smart Citation

The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases

Rahman

Ali

et al. 2018

BioMed Research International

208

128

View full text Add to dashboard Cite

The β-lactams—a large class of diverse compounds—due to their excellent safety profile and broad antimicrobial spectrum are considered to be the most widely used therapeutic class of antibacterials prescribed in human and veterinary clinical practices. This, unfortunately, has also given rise to a continuous increased resistance globally in health care settings as well as in the community due to their permanent selective force driving diversification of the resistance mechanism. Resistance against β-lactams is increasing rapidly as novel β-lactamases, enzymes that degrade β-lactams, are being discovered each day such as recent emergence of extended spectrum β-lactamases (ESBL) that have the ability to inactivate most of the cephalosporins. The complexity and diversity of ESBL are increasing so rapidly that more than 170 variants have thus far been described for only a single genotype, the blaCTX-M-encoding ESBL. This review is to organize all the current updated literature describing genomic features, organization, and mechanism of resistance and mode of dissemination of all known ESBLs.

show abstract

Section: Types Of Esblsmentioning

confidence: 99%

Section: Global Epidemiology Of Esblsmentioning

confidence: 99%

The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases

Rahman

Ali

et al. 2018

BioMed Research International

208

128

View full text Add to dashboard Cite

show abstract

“…TEM-3 and TEM-4 also seem to be widespread, and to be associated with different clones of K. pneumoniae in ICUs [69,70]. TEM-52 is also widespread in Europe, and is associated with Salmonella isolates and, more recently, with E. coli from urinary tract infections [68,[71][72][73].…”

Section: Tem Familymentioning

confidence: 99%

Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe

Cantón

Novais

Valverde

et al. 2008

Clinical Microbiology and Infection

565

316

View full text Add to dashboard Cite

Extended-spectrum beta-lactamases (ESBLs) represent a major threat among resistant bacterial isolates. The first types described were derivatives of the TEM-1, TEM-2 and SHV-1 enzymes during the 1980s in Europe, mainly in Klebsiella pneumoniae associated with nosocomial outbreaks. Nowadays, they are mostly found among Escherichia coli isolates in community-acquired infections, with an increasing occurrence of CTX-M enzymes. The prevalence of ESBLs in Europe is higher than in the USA but lower than in Asia and South America. However, important differences among European countries have been observed. Spread of mobile genetic elements, mainly epidemic plasmids, and the dispersion of specific clones have been responsible for the increase in ESBL-producing isolates, such as those with TEM-4, TEM-24, TEM-52, SHV-12, CTX-M-9, CTX-M-14, CTX-M-3, CTX-M-15 and CTX-M-32 enzymes.

show abstract

“…Antimicrobial resistance to cephalosphorin is conferred by extended-spectrum β-lactamases (ESBL) and plasmid-mediated AmpC β-lactamases (PABL) [9]. ESBL-producing Salmonella isolates produce CTX-M, TEM, OXA or SHV-derived ESBL [6,8,10,11]. Recently, Salmonella has developed resistance to cephalosporin through the transmission of PABL [12], of which CMY-2 is the most common.…”

Section: Introductionmentioning

confidence: 99%

Plasmid-mediated AmpC β-lactamase (CMY-2) gene in Salmonella typhimurium isolated from diarrheic pigs in South Korea

et al. 2014

View full text Add to dashboard Cite

AbstractsBackgroundSalmonella resistant to third-generation cephalosporin has been isolated from an increasing number of animals worldwide. The purpose of this study was to examine ESBL (extended-spectrum β-lactamases)-producing and PABL (plasmid-mediated AmpC β-lactamases)-producing Salmonella isolates from pigs in South Korea.ResultsSalmonella Typhimurium KVCC-BA1300259 was resistant to ampicillin, amoxicillin/clavulanic acid, cephalothin, chloramphenicol, florfenicol, cefoxithin, gentamicin, nalidixic acid, trimethoprim/sulfamethoxazole, tetracycline, and ceftiofur. The results of a double-disk synergy test and PCR confirmed that the isolate produced CMY-2 (PABL). Analysis of plasmid incompatibility (Inc) groups revealed the presence of IncA/C and IncFIB, indicating antimicrobial resistance. This study is the first to identify S. Typhimurium isolates harboring CMY-2 in pigs in South Korea.ConclusionsThe presence of CMY-2 in pigs poses a significant threat of possible horizontal spread between animals and humans.

show abstract

Salmonella enterica serovar Enteritidis producing a TEM-52 β-lactamase: first report in Spain

Cited by 5 publications

References 7 publications

The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases

The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases

Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe

Plasmid-mediated AmpC β-lactamase (CMY-2) gene in Salmonella typhimurium isolated from diarrheic pigs in South Korea

Contact Info

Product

Resources

About